- Details
- Description
-
Packaging Size30capsules/bottle
-
Strength10mg
-
CompositonSeladelpar
-
TreatmentPrimary Biliary Cholangitis
-
Formcapslue
-
BrandLuciSelade
-
Quantity Unit10mg*30c/Box
-
ManufacturerLucius Pharmaceuticals (Lao) Co.,Ltd
About Seladelpar
Seladelpar is a medication used for the treatment of primary biliary cholangitis. It is used as the lysine dihydrate salt. It is a peroxisome proliferator-activated receptor delta (PPARδ) receptor agonist.
Primary Biliary Cholangitis
Indicated for primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy if unable to tolerate UDCA
10 mg PO qDay
Dosage Modifications
Coadministration with bile acid sequestrants
- Administer seladelpar at least 4 hr before or 4 hr after taking bile acid sequestrants, or at the greatest possible interval
Renal impairment
- Mild, moderate, or severe: No dosage adjustment recommended
- ESRD on dialysis: Not studied
Hepatic impairment
- Mild (Child-Pugh A): No dosage adjustment recommended
-
Decompensated cirrhosis
- Safety and efficacy not established; not recommended with decompensated cirrhosis (eg, ascites, variceal bleeding, hepatic encephalopathy)
- Monitor patients with cirrhosis for evidence of decompensation
- Consider discontinuing if progresses to moderate or severe impairment (Child-Pugh B or C)